80 related articles for article (PubMed ID: 21270424)
1. Proliferative and molecular effects of the dual PPARalpha/gamma agonist tesaglitazar in rat adipose tissues: relevance for induction of fibrosarcoma.
Glinghammar B; Berg AL; Bjurström S; Stockling K; Blomgren B; Westerberg R; Skånberg I; Hellmold H; Andersson U
Toxicol Pathol; 2011 Feb; 39(2):325-36. PubMed ID: 21270424
[TBL] [Abstract][Full Text] [Related]
2. Tesaglitazar, a PPARalpha/gamma agonist, induces interstitial mesenchymal cell DNA synthesis and fibrosarcomas in subcutaneous tissues in rats.
Hellmold H; Zhang H; Andersson U; Blomgren B; Holland T; Berg AL; Elebring M; Sjögren N; Bamberg K; Dahl B; Westerberg R; Dillner B; Tugwood J; Tugwood J; Roberts R; Lundholm E; Camejo G; Skånberg I; Evans J
Toxicol Sci; 2007 Jul; 98(1):63-74. PubMed ID: 17468185
[TBL] [Abstract][Full Text] [Related]
3. Peroxisome proliferator activated receptor alpha/gamma dual agonist tesaglitazar attenuates diabetic nephropathy in db/db mice.
Cha DR; Zhang X; Zhang Y; Wu J; Su D; Han JY; Fang X; Yu B; Breyer MD; Guan Y
Diabetes; 2007 Aug; 56(8):2036-45. PubMed ID: 17536062
[TBL] [Abstract][Full Text] [Related]
4. Food does not affect the pharmacokinetics of tesaglitazar, a novel dual peroxisome proliferator-activated receptor alpha/gamma agonist.
Samuelsson S; Johansson S; Halldórsdóttir S; Stenhoff H; Ohman KP
J Clin Pharmacol; 2006 Sep; 46(9):1017-22. PubMed ID: 16920896
[TBL] [Abstract][Full Text] [Related]
5. Dual PPARalpha/gamma agonist tesaglitazar reduces atherosclerosis in insulin-resistant and hypercholesterolemic ApoE*3Leiden mice.
Zadelaar AS; Boesten LS; Jukema JW; van Vlijmen BJ; Kooistra T; Emeis JJ; Lundholm E; Camejo G; Havekes LM
Arterioscler Thromb Vasc Biol; 2006 Nov; 26(11):2560-6. PubMed ID: 16931788
[TBL] [Abstract][Full Text] [Related]
6. Tesaglitazar, a dual PPAR-α/γ agonist, hamster carcinogenicity, investigative animal and clinical studies.
Lindblom P; Berg AL; Zhang H; Westerberg R; Tugwood J; Lundgren H; Marcusson-Ståhl M; Sjögren N; Blomgren B; Öhman P; Skånberg I; Evans J; Hellmold H
Toxicol Pathol; 2012; 40(1):18-32. PubMed ID: 22131108
[TBL] [Abstract][Full Text] [Related]
7.
Osinski V; Bauknight DK; Dasa SSK; Harms MJ; Kroon T; Marshall MA; Garmey JC; Nguyen AT; Hartman J; Upadhye A; Srikakulapu P; Zhou A; O'Mahony G; Klibanov AL; Kelly KA; Boucher J; McNamara CA
Theranostics; 2020; 10(2):585-601. PubMed ID: 31903139
[TBL] [Abstract][Full Text] [Related]
8. The dual peroxisome proliferator-activated receptor alpha/gamma agonist tesaglitazar further improves the lipid profile in dyslipidemic subjects treated with atorvastatin.
Tonstad S; Retterstøl K; Ose L; Ohman KP; Lindberg MB; Svensson M
Metabolism; 2007 Sep; 56(9):1285-92. PubMed ID: 17697874
[TBL] [Abstract][Full Text] [Related]
9. Tesaglitazar.
Kamber N; Davis TM
IDrugs; 2005 Nov; 8(11):927-35. PubMed ID: 16254788
[TBL] [Abstract][Full Text] [Related]
10. Quantitative image analysis in adipose tissue using an automated image analysis system: differential effects of peroxisome proliferator-activated receptor-alpha and -gamma agonist on white and brown adipose tissue morphology in AKR obese and db/db diabetic mice.
Okamoto Y; Higashiyama H; Inoue H; Kanematsu M; Kinoshita M; Asano S
Pathol Int; 2007 Jun; 57(6):369-77. PubMed ID: 17539968
[TBL] [Abstract][Full Text] [Related]
11. Peroxisome proliferator-activated receptor (PPAR) activation induces tissue-specific effects on fatty acid uptake and metabolism in vivo--a study using the novel PPARalpha/gamma agonist tesaglitazar.
Hegarty BD; Furler SM; Oakes ND; Kraegen EW; Cooney GJ
Endocrinology; 2004 Jul; 145(7):3158-64. PubMed ID: 15059948
[TBL] [Abstract][Full Text] [Related]
12. Comparative gene expression profiles induced by PPARγ and PPARα/γ agonists in rat hepatocytes.
Rogue A; Renaud MP; Claude N; Guillouzo A; Spire C
Toxicol Appl Pharmacol; 2011 Jul; 254(1):18-31. PubMed ID: 21515302
[TBL] [Abstract][Full Text] [Related]
13. [Peroxisome proliferator-activated receptor α/γ agonist tesaglitazar stabilizes atherosclerotic plaque in diabetic low density lipoprotein receptor knockout mice].
Zhang BC; Li XK; Che WL; Li WM; Hou L; Wei YD; Xu YW
Zhonghua Xin Xue Guan Bing Za Zhi; 2013 Feb; 41(2):143-9. PubMed ID: 23710746
[TBL] [Abstract][Full Text] [Related]
14. Effect of PPAR-alpha and -gamma agonist on the expression of visfatin, adiponectin, and TNF-alpha in visceral fat of OLETF rats.
Choi KC; Ryu OH; Lee KW; Kim HY; Seo JA; Kim SG; Kim NH; Choi DS; Baik SH; Choi KM
Biochem Biophys Res Commun; 2005 Oct; 336(3):747-53. PubMed ID: 16157299
[TBL] [Abstract][Full Text] [Related]
15. Cadmium reduces adipocyte size and expression levels of adiponectin and Peg1/Mest in adipose tissue.
Kawakami T; Sugimoto H; Furuichi R; Kadota Y; Inoue M; Setsu K; Suzuki S; Sato M
Toxicology; 2010 Jan; 267(1-3):20-6. PubMed ID: 19666079
[TBL] [Abstract][Full Text] [Related]
16. The Korean traditional medicine gyeongshingangjeehwan inhibits adipocyte hypertrophy and visceral adipose tissue accumulation by activating PPARalpha actions in rat white adipose tissues.
Shin SS; Jung YS; Yoon KH; Choi S; Hong Y; Park D; Lee H; Seo BI; Lee HY; Yoon M
J Ethnopharmacol; 2010 Jan; 127(1):47-54. PubMed ID: 19799979
[TBL] [Abstract][Full Text] [Related]
17. Tesaglitazar, a dual peroxisome proliferator-activated receptor agonist (PPAR alpha/gamma), improves metabolic abnormalities and reduces renal injury in obese Zucker rats.
Liao J; Soltani Z; Ebenezer P; Isidro-Carrión AA; Zhang R; Asghar A; Aguilar E; Francis J; Hu X; Ferder L; Reisin E
Nephron Exp Nephrol; 2010; 114(2):e61-8. PubMed ID: 19887847
[TBL] [Abstract][Full Text] [Related]
18. Tesaglitazar, a dual peroxisome proliferator-activated receptor alpha/gamma agonist, improves apolipoprotein levels in non-diabetic subjects with insulin resistance.
Schuster H; Fagerberg B; Edwards S; Halmos T; Lopatynski J; Stender S; Birketvedt GS; Tonstad S; Gause-Nilsson I; Halldórsdóttir S; Ohman KP;
Atherosclerosis; 2008 Mar; 197(1):355-62. PubMed ID: 17631296
[TBL] [Abstract][Full Text] [Related]
19. PPAR-gamma2 expression in response to cafeteria diet: gender- and depot-specific effects.
Rodríguez E; Ribot J; Rodríguez AM; Palou A
Obes Res; 2004 Sep; 12(9):1455-63. PubMed ID: 15483210
[TBL] [Abstract][Full Text] [Related]
20. Berberine regulates peroxisome proliferator-activated receptors and positive transcription elongation factor b expression in diabetic adipocytes.
Zhou J; Zhou S
Eur J Pharmacol; 2010 Dec; 649(1-3):390-7. PubMed ID: 20868663
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
